1Moe S, Drueke T, Cunningham J, et al. Definition, evaluation, and classification of renal osteodystrephy : a position statement from Kid-ney Disease : Improving Global Outcomes ( KDIGO ) [ J ]. Kidney Int, 2006,69( 11 ) : 1945-1953.
2黎磊石,刘志红主编.中国肾脏病学[M].北京:人民军医出版社,2008,1328-1338
3Rhee H, Song SH, Kwak IS, et al. Persistently low intact parathyroid hormone levels predict a progression of aortic arch calcification in inci- dent hemedialysis patients [J]. Clin Exp Nephrol, 2012,16( 1 ) :56-61.
4Frazao JM, Martins P. Adynamie bone disease: clinical and thera- peutic implications [J]. Curr Opin Nephrol Hypertens, 2009,18 (4) :303-307.
5Gal-Moscovici A, Popovtzer MM. New worldwide trends in presenta- tion of renal osteodystrophy and its relationship to parathyroid hor- mone levels [J]. Clin Nephrol, 2005,63 (4) : 284-289.
4Chu P,Chao TY,Lin YF,et al.Correlation between histomorphometric parameters Of bone resorption and serum type 5b tartrate -resistent acid phosphatase in uremic patients on maintenance hemodialysis[J].Am J Kidney Dis,2003,41(5):1 052-1 059.
5National Kidney Foundation:K/DOQI clinical practice guidlines for bone metabolism and disease in chronic kidney dieease[J].Am J Kidney dis,2003,42:S1-S202.
6Moe S,Dr(u)eke T,Cunningham J,et al.Definition,evaluation,and classification of renal osteodystrophy:A position statement from Kidney Disease:Improving Global Outcomes(KDIGO)[J].Kidney International,2006,69:1945-1953.
7Slatopolsky E,Finch J,Clay P,et al.A novel machanism for skeletal resistance in uremia[J].Kidney Int,2000,58:753-761.
8Duarte ME,Peixoto AL,Pacheco AS.The spectrum of bone disease in 200 chronic hemodialysis patients:a correlation between clinical,biochemical and histological findings[J].Sao Paulo Med J,1998,116(5):1 790-1 797.
9Gal-Moscovici A,Popovtzer MM.New worldwide trends in presentation of renal Osteodystrophy and its relationship to parathyroid hormone levers[J].Clin Nephrol,2005,63(4):284-289.
10Lehmann G,Stein G,Hullerr M,et al.Specific measurment of PTH(1-84) in various forms of ROD as assessed by bone histomorphometry[J].Kidney Int,2005,68:1 206-1 214.
9Patel VA,Logan A, Watkinson JC,et al. Paracrinicity: the story of 30 years of cellular pituitary crosstalk[ J]. Am J Physiol Endocrinol Metab ,2008,20( 1 ) : 1 - 70.
10Adragao T, Pires A, Birne R, et al. A plain X - ray vascular calcifi- cation score is associated with arterial stiffness and mortality in dial- ysis patients [ J ]. Nephrol Dial Transplant, 2009,24 ( 3 ) : 997 - 1002.
